![](https://www.diabetesnews.com/wp-content/uploads/2014/06/insulin-1-3c0e963869bf5abd8a8bba77ccf1818be51f46ac-s40-c85-150x150.jpg)
The FDA has cleared The Bigfoot Unity AI Diabetes Management System by Bigfoot Biomedical, an artificially intelligent insulin pen cap, for use in type 1 and type 2 diabetes patients aged 12 or older. The device has the potential to make insulin dosing much less burdensome for many patients. Read more